# Clustering Approach 3 : RPPA_CNMF
Index	Clinical feature name	Test type	P value	Comment
1	Time to Death	logrank test	0.914042201063924	Range of duration = 2.56 to 345.96, nDeath = 47, nCensor = 47
2	AGE	ANOVA	0.661077915136322	Range of values = 18 to 83, Mean = 56.9368, StdDev = 15.9279
3	PRIMARY.SITE.OF.DISEASE	Fisher's exact test	0.0294652600225668	nTypes = 2 (REGIONAL CUTANEOUS OR SUBCUTANEOUS TISSUE (INCLUDES SATELLITE AND IN-TRANSIT METASTASIS)/REGIONAL LYMPH NODE), nPatients = 15/80
4	GENDER	Fisher's exact test	0.765885955681887	nTypes = 2 (FEMALE/MALE), nPatients = 35/60
5	DISTANT.METASTASIS	Chi-square test	0.512813616557475	nTypes = 4 (M0/M1/M1B/M1C), nPatients = 78/1/2/1, nMissing = 13
6	LYMPH.NODE.METASTASIS	Chi-square test	0.165298180025175	nTypes = 9 (N0/N1/N1A/N1B/N2A/N2B/N2C/N3/NX), nPatients = 48/2/3/9/2/5/3/9/2, nMissing = 12
7	TUMOR.STAGECODE	ANOVA	NA	Range of values = Inf to -Inf, Mean = NaN, StdDev = NA, nMissing = 95
8	NEOPLASM.DISEASESTAGE	Chi-square test	0.0360115046681933	nTypes = 13 (I OR II NOS/STAGE I/STAGE IA/STAGE IB/STAGE II/STAGE IIA/STAGE IIB/STAGE IIC/STAGE III/STAGE IIIA/STAGE IIIB/STAGE IIIC/STAGE IV), nPatients = 1/11/7/7/9/5/4/2/5/2/9/11/3, nMissing = 19